Glassia (alpha.1-proteinase inhibitor human)
(ALPHA.1-PROTEINASE INHIBITOR HUMAN)Takeda Pharmaceuticals America, Inc.
Usage: GLASSIA is indicated for chronic augmentation and maintenance therapy in individuals with emphysema due to severe hereditary Alpha-1 Proteinase Inhibitor deficiency (AAT deficiency). Its effects on pulmonary exacerbations and emphysema progression are not conclusively demonstrated. It is not for use in patients without established severe deficiency.